Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd
Bullboard Posts
User Avatar Image
(169)
•••
Comment by Noloon Jul 17, 2019 5:05pm
79 Views
Post# 29931771

RE:RE:RE:RE:RE:RE:7-10 is Wayy Over... Time For Answers

RE:RE:RE:RE:RE:RE:7-10 is Wayy Over... Time For Answers
StackPaypa wrote: This is called a "check-mate" for all the pumpers


Just out of curiosity, because you asked me to clarify one of my previous posts (which I gladly did), I will do the same here: who exactly are you calling a pumper?

A pumper is someone who overhype a stock with the hope of making its sp rise so they can sell and make a profit out of the said scam. We, the longs on this board, do not have the intention to sell anytime soon. We haven't sold at .20 or .19 or .18 or .17 or .16 and so on. We are keeping our shares because we believe that a better situation is coming. If we are wrong, then this becomes our problem. 

You will see us discuss about upcoming news, possible contracts, PPs or whatever subjects related to the company we have invested in. We believe good things are going to happen, even if there's a delay. Do we have undeniable proof of that? No. We hope so, though. 

So, let me ask again: who exactly here are you calling a pumper?



Bullboard Posts
Dealroom for high-potential pre-IPO opportunities